-
1
-
-
0036693737
-
Genetically modified Streptococcus mutans for the prevention of dental caries
-
HILLMAN JD: Genetically modified Streptococcus mutans for the prevention of dental caries. Antonie Van Leeuwenhoek. (2002) 82:361-366.
-
(2002)
Antonie Van Leeuwenhoek
, vol.82
, pp. 361-366
-
-
Hillman, J.D.1
-
2
-
-
33646352688
-
A recombinant probiotic for treatment and prevention of cholera
-
FOCARETA A, PATON JC, MORONA R, COOK J, PATON AW: A recombinant probiotic for treatment and prevention of cholera. Gastroenterology (2006) 130:1688-1695.
-
(2006)
Gastroenterology
, vol.130
, pp. 1688-1695
-
-
Focareta, A.1
Paton, J.C.2
Morona, R.3
Cook, J.4
Paton, A.W.5
-
3
-
-
33646007668
-
Designer probiotics for prevention of enteric infections
-
PATON AW, MORONA R, PATON JC: Designer probiotics for prevention of enteric infections. Nat. Rev. Microbiol (2006), 4:193-200.
-
(2006)
Nat. Rev. Microbiol
, vol.4
, pp. 193-200
-
-
Paton, A.W.1
Morona, R.2
Paton, J.C.3
-
4
-
-
19044375218
-
Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea
-
PATON AW, JENNINGS MP, MORONA R et al.: Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. Gastroenterology (2005) 128:1219-1228.
-
(2005)
Gastroenterology
, vol.128
, pp. 1219-1228
-
-
Paton, A.W.1
Jennings, M.P.2
Morona, R.3
-
5
-
-
0035204893
-
Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody
-
OGGIONI MR, BENINATI C, BOCCANERA M et al.: Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody. Int. Rev. Immunol. (2001) 20:275-287.
-
(2001)
Int. Rev. Immunol.
, vol.20
, pp. 275-287
-
-
Oggioni, M.R.1
Beninati, C.2
Boccanera, M.3
-
6
-
-
3042559646
-
In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii
-
RICCI S, MACCHIA G, RUGGIERO P et al.: In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii. BMC. Biotechnol (2003) 3:15.
-
(2003)
BMC. Biotechnol
, vol.3
, pp. 15
-
-
Ricci, S.1
Macchia, G.2
Ruggiero, P.3
-
7
-
-
0037546931
-
+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag
-
+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag. J. Immunol (2003) 170:5176-5187.
-
(2003)
J. Immunol
, vol.170
, pp. 5176-5187
-
-
Peters, C.1
Peng, X.2
Douven, D.3
Pan, Z.K.4
Paterson, Y.5
-
8
-
-
0036322876
-
The peptidyl-prolyl isomerase motif is lacking in PmpA, the PrsA-like protein involved in the secretion machinery of Lactococcus lactis
-
DROUAULT S, ANBA J, BONNEAU S, BOLOTIN A, EHRLICH SD, RENAULT P: The peptidyl-prolyl isomerase motif is lacking in PmpA, the PrsA-like protein involved in the secretion machinery of Lactococcus lactis. Appl. Environ. Microbiol. (2002) 68:3932-3942.
-
(2002)
Appl. Environ. Microbiol.
, vol.68
, pp. 3932-3942
-
-
Drouault, S.1
Anba, J.2
Bonneau, S.3
Bolotin, A.4
Ehrlich, S.D.5
Renault, P.6
-
9
-
-
33845519008
-
Constitutive delivery of bovine {beta}-Lactoglobulin to the digestive tract of gnotobiotic mice by engineered Lactobacillus casei
-
(in press)
-
HAZEBROUCK S, OOZEER R, ADEL-PATIENT K et al.: Constitutive delivery of bovine {beta}-Lactoglobulin to the digestive tract of gnotobiotic mice by engineered Lactobacillus casei. Appl. Environ. Microbiol. (2006) (in press)
-
(2006)
Appl. Environ. Microbiol.
-
-
Hazebrouck, S.1
Oozeer, R.2
Adel-Patient, K.3
-
10
-
-
4143082646
-
Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice
-
VANDENBROUCKE K, HANS W, VAN HUYSSE J et al.: Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology (2004) 127:502-513.
-
(2004)
Gastroenterology
, vol.127
, pp. 502-513
-
-
Vandenbroucke, K.1
Hans, W.2
Van Huysse, J.3
-
11
-
-
33744933432
-
A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease
-
BRAAT H, ROTTIERS P, HOMMES DW et al.: A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. (2006) 4:754-759.
-
(2006)
Clin. Gastroenterol. Hepatol.
, vol.4
, pp. 754-759
-
-
Braat, H.1
Rottiers, P.2
Hommes, D.W.3
-
12
-
-
0037820426
-
Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10
-
STEIDLER L, NEIRYNCK S, HUYGHEBAERT N et al.: Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. (2003), 21:785-789.
-
(2003)
Nat. Biotechnol.
, vol.21
, pp. 785-789
-
-
Steidler, L.1
Neirynck, S.2
Huyghebaert, N.3
-
13
-
-
33749532310
-
Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N
-
LIU X, LAGENAUR LA, SIMPSON DA et al.: Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. Antimicrob. Agents Chemother. (2006) 50:3250-3259.
-
(2006)
Antimicrob. Agents Chemother.
, vol.50
, pp. 3250-3259
-
-
Liu, X.1
Lagenaur, L.A.2
Simpson, D.A.3
-
14
-
-
0035989641
-
In situ delivery of passive immunity by lactobacilli producing single-chain antibodies
-
KRUGER C, HU Y, PAN Q et al.: In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat. Biotechnol. (2002) 20:702-706.
-
(2002)
Nat. Biotechnol.
, vol.20
, pp. 702-706
-
-
Kruger, C.1
Hu, Y.2
Pan, Q.3
-
15
-
-
0031815046
-
Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine
-
STEIDLER L, ROBINSON K, CHAMBERLAIN L et al.: Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect. Immun. (1998) 66:3183-3189.
-
(1998)
Infect. Immun.
, vol.66
, pp. 3183-3189
-
-
Steidler, L.1
Robinson, K.2
Chamberlain, L.3
-
16
-
-
33745139808
-
Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1
-
DANIEL C, REPA A, WILD C et al.: Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy (2006) 61:812-819.
-
(2006)
Allergy
, vol.61
, pp. 812-819
-
-
Daniel, C.1
Repa, A.2
Wild, C.3
|